spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Elixir Pharmaceuticals 

 HSMN NewsFeed - 24 Jan 2024
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 25 Jun 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2013
InVivo Therapeutics Appoints Gregory D. Perry as Interim CFO
Devices Neurosurgery Personnel
 HSMN NewsFeed - 1 Dec 2010
Accelerator Corporation Finances Eleventh Startup with Acylin Therapeutics, Inc.
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jun 2010
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2010
Cerulean Pharma Inc. Appoints Two Senior Executives to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Oct 2007
Biotech Veteran Joins AerovectRx as CEO
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 25 Oct 2007
Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2007
Elixir Pharmaceuticals Initiates Final Phase III Clinical Study Prior to NDA
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 29 Jan 2007
Elixir Pharmaceuticals Names Gregory D. Perry as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2007
Elixir Pharmaceuticals Presents New Data Highlighting Ghrelin Inhibition as a Potential Method for Regulating Metabolism and Treating Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 29 Nov 2006
Hercules Provides $15 Million of Financing to Elixir Pharmaceuticals, Inc., a Leading Biopharmaceutical Company
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2006
Elixir Pharmaceuticals Raises $46 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Nov 2006
Cohera Medical, Inc. Announces Dr. Doros Platika Elected as Chairman of the Board of Directors
Devices Surgery Personnel
Return to NewsFeed  

 Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 7 additional stories matching:
Elixir Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.